Case Study:
AI for reshaping content across channels/formats/uses and predicting most impactful variants
AI for reshaping content across channels/formats/uses and predicting most impactful variants
The Client Challenge
Humans make educated guesses as to how to reshape content for impact across different channels, formats and use cases. This can be vastly improved with AI.
The Solution
- Specialized approach to language optimization that blends natural language processing (NLP) with experimental design principles. Use a combination of:
- Machine learning models trained on marketing language and consumer response data to identify patterns between specific language elements and engagement metrics
- Semantic decomposition technology that breaks marketing messages into functional components (emotional language, descriptions, calls-to-action, formatting elements)
- A generative system capable of producing numerous linguistically diverse variants of messages that convey the same core meaning but use different emotional appeals, phrasings, and structural elements
- A sophisticated testing framework that systematically evaluates these message variants against control versions through randomized experiments (A/B or multivariate testing)
- Reinforcement learning mechanisms that continuously refine the system’s understanding of which language elements most effectively drive desired consumer behaviours across different segments and channel
The Outcome
- Saved significant time (weeks per content piece was saved) in reshaping content for different audiences and markets, and generated strong impact from materials in terms of longer engagement and lift in NRx
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
Pharma’s Patent Cliff is Here. Why AI Strategy Matters Now More Than Ever.
Dr Andree Bates
The pharmaceutical industry is entering a decisive period. Over the next several years, many of its most valuable brands will lose exclusivity, putting a substantial
The Hidden Cost of Having No AI Strategy (Spoiler: It’s Not What You Think)
Dr Andree Bates
In the past few years, almost 70% of biopharma companies have initiated AI initiatives. Yet, fewer than 20% report a cohesive AI strategy at the
Are LLMs Already On Their Way to Being Obsolete?
Dr Andree Bates
The AI world is racing forward with near-religious confidence in large language models, yet one of the field’s most influential pioneers is already drafting their